key: cord-0662963-psmnzioa
authors: Angelopoulos, Anastasios Nikolas; Pathak, Reese; Varma, Rohit; Jordan, Michael I.
title: Identifying and Correcting Bias from Time- and Severity- Dependent Reporting Rates in the Estimation of the COVID-19 Case Fatality Rate
date: 2020-03-19
journal: nan
DOI: nan
sha: 8a822b32784ff2c889747ea279be3e1c6391cd27
doc_id: 662963
cord_uid: psmnzioa

Background: COVID-19 is an ongoing pandemic with over 400,000 confirmed cases and large variability in its reported case fatality rate (CFR). CFR is an epidemiological measure of severity which can affect policymaking and public health responses to the disease. As we are in the middle of an active outbreak, estimating this measure will necessarily involve correcting for time- and severity- dependent reporting of cases, and time-lags in observed patient outcomes. Methods: We carry out a theoretical analysis of current estimators of the CFR. We adapt a standard statistical technique, expectation maximization (EM), in a form previously developed for pandemic influenzas to correct for time- and severity- dependent reporting in the estimated CFR of COVID-19. Code is available at https://github.com/aangelopoulos/cfr-covid-19 . Findings: We find that the na"{i}ve estimator of CFR is asymptotically biased for the true CFR. To compensate for both of these variables we apply an expectation maximization strategy previously developed for emerging pathogens such as pandemic influenza. We obtain a CFR estimate of 2.4% for COVID-19. We also show results of our method for relative CFR by nation. Finally, we release our code on GitHub so it can be used as more data becomes available globally. Interpretation: The current strategy of estimating the CFR by dividing the number of deaths by the number of cases should not be used anymore as it is unreliable. Moving forward we suggest instead the use of maximum likelihood models which correct for time-dependent bias. This may allow public health organizations and local, state, and national governments to more accurately direct resources (e.g. test kits and vaccines) to places that would be most in need by compensating for the time delay inherent in this urgent ongoing pandemic.

The 2019 novel Coronavirus (SARS-COV-2) outbreak in China has claimed at least 18, 915 lives out of 422, 915 confirmed cases worldwide, of which 108, 573 have recovered (March 23). 1 Because the basic reproduction number R 0 of the virus is high (est. 2 to 3), 2 public health organizations and local, state, and national governments may need to prepare to allocate resources to populations especially susceptible to death during this pandemic. Therefore it is critical to know the absolute case fatality ratio (CFR) of COVID-19 and the relative CFRs between different populations. * angelopoulos@berkeley.edu However, as researchers have recently pointed out, the naïve estimate, 4.4%, is obtained from a biased estimator. 3, 4 Despite this bias, the estimate continues to be used, reported, and cited in major publications. 5, 6 This manuscript proposes a bias-corrected estimate based on approximate maximum likelihood estimation, first introduced in Reich et al. 7 To our knowledge, this method has not yet been applied to COVID-19 data 1 that has been made publicly available. 1 This method permits us to estimate bias-corrected CFR over time, and also allows estimation of relative CFR based on covariates such as geography and age. Plot of time series of recoveries, R t , deaths D t , and cases C t , plotted against time index t, on a logarithmic scale. We additionally plot the number of total diagnoses, R t + D t . Right. A plot of E naive and E obs as time series.

We access publically available data courtesy of Johns Hopkins University, consisting of time-series data of recoveries, deaths, and confirmed cases stratified across several dozen groups (in this case, geographic locations). 1 We denote cohorts or groups of cases by indices g, belonging to a set G. For time points t = 1, 2, . . . , T = 41, we collect daily data that we describe presently: for each group g ∈ G we collect R g t , D g t , and C g t , which correspond to the number of recoveries, deaths, and cases reported on day t within group g. We drop the group superscript g for population quantities:

In early March 2020, the WHO estimate of the CFR, 3.4% was widely reported. 8, 9 This estimate is obtained from a naïve estimator 2 , specificially, the raw proportion of deaths among confirmed cases. Formally, as of March 6, 2020, 

Evidence before this study After the wake of the last two fatal coronavirus infections, severe acute respiratory syndrome coronavirus (SARS), and the Middle East respiratory syndrome coronavirus (MERS), epidemiologists developed strategies for correcting bias in the estimates of case fatality rate (CFR). We searched PubMed and Google Scholar for articles published up to March 10, 2020, using keywords such as "COVID-19," "case fatality rate," and "biased estimator." No estimator which properly compensated for time-dependent reporting of COVID-19 cases was found. In contrast, even highly-cited articles continually report a CFR which uses a biased estimation strategy. We posted this paper on March 13, 2020, but have updated our estimates as the epidemic has grown.

Added value of this study We report results from a likelihood model validated on data from past pandemic influenzas which accounts for the bias introduced by time-and severitydependent reporting rates during the ongoing COVID-19 pandemic. Using our estimator, the CFR, as of March 23, 2020, is 2.4%. We report relative CFR estimates which correct for these factor by nation. We provide a codebase and methodology which will allow the public health community to easily apply our estimation strategy to the absolute and relative CFR of COVID-19 as more data becomes available.

Implications of all the available evidence We prove in Appendix A and Appendix B that the simple estimators being reported today are misleading. A likelihood model such as the one we use should either support or supplant the intuitive but incorrect strategy of dividing the number of deaths by the number of cases. the unconditional fatality rate of the disease unless the covariance between being diagnosed and dying is exactly equal to the probability of being diagnosed. Even asymptotically, the performance of this estimator becomes unboundedly bad as the CFR goes to zero. Furthermore, the naïve estimator of CFR is also biased for the CFR itself. The bias comes from two flawed assumptions. First, at the time of estimation, we have observed all deaths that will happen among diagnosed cases. Second, the reporting rates of cases is the same at all times regardless of severity. We make formalize this argument mathematically in Appendix A. The naïve estimator ignores time-dependent reporting: the denominator of the fraction is growing much faster than the numerator during an active outbreak, as more people become infected (or aware that they are). It is therefore a challenge to disentangle which recoveries should "count" at which time point t. The efficiency of the estimator is also questionable, as it never takes into account the quantity R t (the time series of recovered cases). The naïve estimator is a simplistic estimator: it requires no complex modeling or tuning parameters and is easy to interpret. Furthermore, as we will see, there is no uniformly best method of measuring the CFR. The naïve estimator should be viewed as one in a constellation of estimators which give a heuristic idea of the true CFR. In this work, we suggest applying a correction for timedependent reporting rates which alleviates each of the above problems.

One can view the problems listed in Section 3 as a consequence of "censoring" the data. Methods for handling censored data have been studied for almost 40 years in statistical literature; in particular, in the context of Efron's bootstrap. 10 Several works have already applied the bootstrap to COVID-19 data to find confidence intervals for other epidemiological parameters such as R 0 . 11, 12 This should also be done for the CFR for COVID-19, as Jewell et al. did for SARS. 13 There is also a very simple estimator which only uses observed data, namely

This estimator accounts for the inflation of the denominator in the naïve estimator, but does not take advantage of any information in C {1,...,T } . Furthermore, this estimator makes the further assumption that we observe the same fraction of recovered cases and fatal cases at the time of estimation. We formalize this assertion in Appendix B. Note that in all cases, E obs ≥ E naive . Generally it cannot be said that either estimator is an upper or lower bound on the true CFR due to time delay. The closest work to ours attempts to correct for the time-dependent reporting by picking an single day in the past, and using the denominator of E naive from that day. 14 However, such methods are misleading because they do not compensate for time-and severity-dependent reporting. For example, in the simple case that people do not report the disease until it is in an advanced stage, such a method would break. Instead, we must parameterize a likelihood model which can account for these factors explicitly.

In this section, we explain how, under mild assumptions, the parametric model in Reich et al. can estimate the time-dependent CFR of COVID-19. 7 Specifically, we may outperform E naive and E obs by fitting a model. Indeed, several papers have used maximum likelihood methods to fit parametric models of time-dependent epidemiological quantities using data from past influenzas such as H1N1 and the Spanish flu. 15, 7, 16 A parametric model allows us to "bake in" assumptions about COVID-19 to improve the estimator. For example, using our model, the (unknown) probability that a person who died from COVID-19 was diagnosed is ψ. ψ will vary depending on the day of symptom onset t on and group g (e.g., due to awareness or availability of testing), so we can index it as ψ t on ,g . Similarly, the timeand group-varying probability that a person who recovered from COVID-19 was diagnosed is φ t on ,g . We can also denote the true CFR as p t on ,g . Then, for each person A in group g and onset t on , there are three possibilities:

• Scenario 1: A recovered and was diagnosed, with probability φ t on ,g (1 − p t on ,g );

• Scenario 2: A died and was diagnosed, with probability ψ t on ,g p t on ,g ;

Define N * t on ,g as the (unknown) number of total cases infected at time t on and in group g. Then the three scenarios define a multinomial model with three categories. If we had t on and the time of death/recovery for each COVID-19 patient, the model could be fit analytically. But we do not, so we need an extra assumption: that we Table 1 : Using our likelihood model, the CFR decreases to 2.4 as the mean time to death approaches the true mean of 14. Above, if µ = i, it implies that the experiment was carried out sampling X ∼ N(i, 1), as described in section 6.1. know, conditioned on the death of a patient, the probability that they die on any day t d ≥ t on . This quantity is defined as:

The other key assumptions that makes the fitting of this model possible are that p is not time-dependent (i.e., the CFR is constant over time) and a Poisson assumption. An extensive mathematical treatment and evaluation of this model is in Reich et al. 7 They show that as long as p g stays below 0.05, the estimated CFR is off by less than 10% of its true value. Similarly, it is not very sensitive to misspecification of the distribution of deaths. We will now apply this model to the COVID-19 data. 1 

Using the crudeDataTools package in RStudio, we applied the above model on the open-sourced COVID-19 data. 7 The code is included for reproducibility.

Fourteen vectors of length L, η 14 1 , were chosen to illustrate the estimator's performance as our assumption about the true distribution of deaths changes. We stopped at 14 because that is the current best estimate for the mean time to death. 17 The η (i) were chosen as L evenly spaced points along the domain of the Gaussian probability distribution function, with mean i and unit standard deviation:

We found that the bias-corrected CFR was between 1.7% and 3.6% depending on the chosen η. Table 1 summarizes our results for all values of η. Our results indicate a downward correction of the naïve estimate of 4.4% to 2.4%. More importantly, as more data becomes available, our time-series based methodology will increase in accuracy. It will also be possible to model longer-tailed death distributions as more data points become available. 

It is also important during an ongoing outbreak to estimate the relative CFR. However, as Table 2 indicates, none of the estimators are reliable, and no one estimator is uniformly better than any other. We suggest applying these estimators after more testing has been performed outside China, and we provide code to apply the estimator to the JHU CSSE dataset. 1 It may be therefore best to rely on relative CFRs taken from SARS data and apply them to COVID-19 for the near future, until more data is available.

Our result indicates that after correction for timedependent reporting rates, the WHO estimate of 3.4% (now 4.4%) is likely an overestimate of the true CFR. This fact motivates the methodology that we use. We note that the motivation will only strengthen as the reporting-rate adjusted estimators for relative CFR begin to converge with more testing in Italy, South Korea, Iran, and the United States. We also show that the epidemiological community should be highly skeptical of both E naive and E obs ; they are biased even in generous infinite-data conditions. Our code, released on GitHub with this submission, includes a script which will run the estimator on new COVID-19 data worldwide as it is published.

The authors declare no conflicts.

A.N.A. is funded by the National Science Foundation Graduate Research Fellowship Program. No funding sources played an involvement in the work. The corresponding author has had full access to all the data in the study and final responsibility for the decision to submit for publication.

A.N.A. Literature search, figures, study design, data collection, data analysis, data interpretation, writing. R.P. Literature search, figures, study design, data collection, data analysis, data interpretation, writing. R.V. Data interpretation, writing. M.I.J. Data analysis, data interpretation, writing.

The naive estimator has two major limitations: 1) It does not compensate for the fact that people who become confirmed cases are biased to become more severely ill. 2) It does not compensate for censoring. The first proof deals with 1), and the second deals with 2).

Index the infected population with the integers {1, · · · , N}. Let Z i ∼ Bern(p) be a Bernoulli random variable representing whether or not i died, and let D i ∼ Bern(q) be a Bernoulli random variable representing whether or not i was diagnosed with the virus. Also define

Applying the tower property of conditional expectation and using the independence of the Z i and D i , we have:

Since D 1 is independent of D 2,...,N , we can express the sum in the denominator as a binomial random variable, B ∼ Bino(N − 1, q). Note the fact that E 1 1+B = ((1 − (1 − q) N ))/Nq. Then, evaluating the innermost expectation first:

Finally, substituting for q 1 , we obtain the final form:

Recall that q is the probability of reporting given an infection, and p is the probability of death given an infection. Therefore E naive is biased for p unless both q = 1 and Cov(Z i , D i ) = 0, which is clearly false for any real disease. Interestingly this empirical CFR is not constrained to be an underestimate, and can overestimate p if p ≥ Cov(D 1 ,Z 1 )(1−(1−q) N ) q(1−q) N . Also, if there exists some small probability of dying independent of the disease and the covariance between Z and D is otherwise nonnegative, the (asymptotic) overestimate can get as bad as:

In other words, as the rate of reporting (q) decreases or the covariance between death and reporting increases, the CFR gets worse, ultimately becoming infinitely bad. Part 2), that the naïve estimator of the CFR is biased for the true CFR, can be found in Reich et al. Appendix A. 7

In the same setting as Appendix A Part 2, define: d t,g . . = E[D t,g | N * t,g ] = N * t,g p g ψ t and r t,g .

where F d represents the fraction of confirmed cases who have died by time t, conditioned on their eventual death. Similarly F r represents the fraction of confirmed cases who have recovered by time t, conditioned on their eventual recovery. During an active outbreak, we have F d < 1 and F r < 1. Finally, define T as the current time; all sums over time below have an upper limit of T unless otherwise specified. We seek the asymptotic convergence target of:

By the weak law of large numbers we have: d t,g N * t,g → p g ψ t ,

and similarly,

Now we focus on the denominator. We have to introduce a "smoothness" assumption: the number of infected people at each timestep N * t 1 ,g has a constant ratio with the number of infected people at each other timestep N * t 2 ,g . This is a conservative assumption in any real-world scenario. In particular, as N * t 1 ,g → ∞ and N * t 2 ,g → ∞,

Therefore, we also have by Slutsky's theorem that: d t 1 ,g + r t 1 ,g N * t 2 ,g → λ t 1 ,t 2 ,g (p g ψ t + (1 − p g )φ t ).

Now, applying the weak law of large numbers and our assumption:

Then, by Slutsky's theorem, d t 2 ,g Σ t 1 d t 1 ,g + r t 1 ,g = d t 2 ,g /N * t 2 ,g Σ t 1 (d t 1 ,g + r t 1 ,g )/N * t 2 ,g → p g ψ t Σ t 1 (λ t 1 ,t 2 ,g (p g ψ t + (1 − p g )φ t )) .

Finally, applying the above results to our estimator (and with one final application of Slutsky's theorem to F d and F r ), E obs = Σ t 2 F d (T )p g ψ t F d (T )(Σ t 1 λ t 1 ,t 2 ,g p g ψ t ) + F r (T )(Σ t 1 λ t 1 ,t 2 ,g (1 − p g )φ t ) .

This is clearly a biased estimator of p g .

An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Covid-19Navigating the Uncharted

2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate-a word of caution

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Estimating absolute and relative case fatality ratios from infectious disease surveillance data

Trump makes spurious claims about coronavirus in phone call with Sean Hannity

WHO Director-General's opening remarks at the media briefing on COVID-19 -3

Censored data and the bootstrap

Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv

Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data. medRxiv

Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS). Statistics in medicine

Case fatality rate of novel coronavirus disease 2019 in China. medRxiv

The time required to estimate the case fatality ratio of influenza using only the tip of an iceberg: joint estimation of the virulence and the transmission potential. Computational and mathematical methods in medicine

Use of Poisson regression models in estimating incidence rates and ratios

Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan